Medicare weight loss drug pilot delayed Read in browser

Thank you for reading, dupa dupackia! basic Subscription UPGRADE

M T Wed Th F 22 April, 2026

Discover the latest trends, challenges, and strategies shaping the future of patient experience across 80+ companies. sponsored by Courier Health

presented by This Founder Could­n't Find His Own Clin­i­cal Tri­al. Now He's En­rolling Hun­dreds of Pa­tients for Phar­ma's Biggest Names

news Roche’s multiple sclerosis pill delays relapse, but liver toxicity could need monitoring Medicare indefinitely delays pilot plan to cover weight loss drugs

Apr 28 12:30 pm ET Connection ≠ continuity: Rethinking long-term evidence in the age of tokenization sponsored by PicnicHealth Apr 29 12:00 pm ET From genotype to outcomes: Real-world evidence in glomerular diseases sponsored by Natera May 05 11:00 am ET The path to self-driving: Leveraging agentic AI to drive the future of clinical drug development sponsored by Medable May 12 10:30 am ET Rules of engagement: How G3BP2 paves the way to rationalize novel degrons sponsored by Thermo Fisher May 20 11:00 am ET Application of Simple Western to analysis of antibody target affinity and specificity sponsored by Bio-Techne

US biopharma still leads the world in high-risk drug development, but the road from innovation to access has never been harder to predict. Hear from top executives and investors on how they’re navigating what’s next. Join us.

ENDPOINTS PHARMA Merck's Welireg combo fails in first-line kidney cancer RFK Jr. says China is 'eating our lunch' in biotech advances FDA approves once-daily HIV pill from Merck

in case you missed it 1. Is this pancreatic cancer's 'Herceptin moment'? Revolution Medicines' breakthrough offers hope 2. Flagship’s latest startup aims to solve gene therapy’s thorniest technical challenge 3. News Briefing Carvykti shows promise before multiple myeloma; two megarounds; AZ wins in COPD and kidney disease 4. Soleno sold at a discount to Neurocrine due to dwindling European prospects 5. Personalized CRISPR therapies could soon reach thousands — here’s how 6. CDC won’t publish report showing Covid shots cut likelihood of hospital visits